Literature DB >> 12368705

Vincristine-itraconazole interaction: cause for increasing concern.

Rajeev K Sathiapalan, Abdallah Al-Nasser, Hassan El-Solh, Ibrahim Al-Mohsen, Sulaiman Al-Jumaah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12368705     DOI： 10.1097/00043426-200210000-00023

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN： 1077-4114            Impact factor:   1.289


× No keyword cloud information.
  4 in total

Review 1.  Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.

Authors:  Brad Moriyama; Stacey A Henning; Janice Leung; Oluwaseun Falade-Nwulia; Paul Jarosinski; Scott R Penzak; Thomas J Walsh
Journal:  Mycoses       Date:  2011-11-29       Impact factor: 4.377

2.  Itraconazole prophylaxis in pediatric cancer patients receiving conventional chemotherapy or autologous stem cell transplants.

Authors:  Arne Simon; Mette Besuden; Sandra Vezmar; Carola Hasan; Dagmar Lampe; Sigrid Kreutzberg; Axel Glasmacher; Udo Bode; Gudrun Fleischhack
Journal:  Support Care Cancer       Date:  2006-08-30       Impact factor: 3.603

3.  Clinical Analysis of Adverse Drug Reactions between Vincristine and Triazoles in Children with Acute Lymphoblastic Leukemia.

Authors:  Lihua Yang; Lihua Yu; Xinxin Chen; Yanqun Hu; Bin Wang
Journal:  Med Sci Monit       Date:  2015-06-07

4.  Hyponatremia During Induction Therapy in Distinct Pediatric Oncological Cohorts: A Retrospective Study.

Authors:  Christina Salvador; Robert Salvador; Peter Willeit; Christine Kuntner; Alexandra Haid; Thomas Müller; Gabriele Kropshofer; Roman Crazzolara
Journal:  Front Oncol       Date:  2021-10-29       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.